SEPTInvestingStart Free

ZNTL 10-Q: SEC filing

Zentalis Pharmaceuticals

Filed with the SEC on · accession 0001725160-26-000070

ZNTL filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +1.2% by the first close after the filing.

Summary of the filing

Zentalis Pharmaceuticals filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.

For details, click here →How to read a 10-Q →

Key details

FilerZentalis Pharmaceuticals, Inc.
Collaboration partnerZentera Therapeutics
Collaboration partnerZero Management Inc.

How ZNTL stock reacted

Close before

$1.72

Nov 6, 2026

First close after

+1.16%

$1.74

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ZNTL, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ZNTL?

Click here

Frequently asked questions

What did ZNTL file with the SEC on Nov 9, 2026?

ZNTL filed a 10-Q (SEC filing). Zentalis Pharmaceuticals filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ZNTL stock react to this filing?

ZNTL closed at $1.72 before the filing and $1.74 on Nov 9, 2026 (+1.16%).

Other ZNTL SEC filings

Get alerts when ZNTL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
ZNTL overviewZNTL analysisZNTL newsLatest SEC filings